Biomarkers for nonclinical infusion reactions in marketed biotherapeutics and considerations for study design Fulltext Access 15 Pages 2017
Simultaneous exposures to heat and chemicals and the impact on toxicokinetics and biomonitoring Fulltext Access 6 Pages 2017
The need for non- or minimally-invasive biomonitoring strategies and the development of pharmacokinetic/pharmacodynamic models for quantification Fulltext Access 7 Pages 2017
Alternative sampling strategies for the assessment of biomarkers of exposure Fulltext Access 20 Pages 2017
Qualification of safety biomarkers for use in drug development: What has been achieved and what is the path forward? Fulltext Access 23 Pages 2017
Translational trio of myocardial biomarkers for prediction, monitoring and controlling toxicologic response: Mechanistic (high content analysis), leakage (high-sensitivity cardiac troponin I) and function biomarkers (B-type natriuretic peptide) Fulltext Access 5 Pages 2017